Scarred Uterus
6
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Laminaria Japonicum Followed by Misoprostol Versus Misoprostol Alone for Mid-Trimester Abortion Induction in Scarred Uterus
Uterine Scar Resection During Repeat Cesarean Delivery to Prevent Uterine Niche Formation
Planned Mode of Delivery After Caesarean: a Comparative Prospective National Population-based Cohort Study
Birth Cohort Study of China Medical University
Abnormal Placenta Plant Disease Early Diagnosis and Individualized Treatment Research
A Comparison of Balloon Catheter Versus Ocytocin for Cervical Ripening on Scarred Uterus With Unfavorable Cervix